Ptc Therapeutics (PTCT) Return on Assets (2016 - 2025)
Ptc Therapeutics (PTCT) has 13 years of Return on Assets data on record, last reported at 0.43% in Q4 2025.
- For Q4 2025, Return on Assets rose 30.0% year-over-year to 0.43%; the TTM value through Dec 2025 reached 0.43%, up 30.0%, while the annual FY2025 figure was 0.54%, 41.0% up from the prior year.
- Return on Assets reached 0.43% in Q4 2025 per PTCT's latest filing, down from 0.49% in the prior quarter.
- Across five years, Return on Assets topped out at 0.55% in Q1 2025 and bottomed at 0.4% in Q4 2023.
- Average Return on Assets over 5 years is 0.05%, with a median of 0.19% recorded in 2021.
- Peak YoY movement for Return on Assets: crashed -40bps in 2023, then soared 86bps in 2025.
- A 5-year view of Return on Assets shows it stood at 0.26% in 2021, then skyrocketed by 100bps to 0.0% in 2022, then tumbled by -31783bps to 0.4% in 2023, then surged by 133bps to 0.13% in 2024, then surged by 222bps to 0.43% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Assets were 0.43% in Q4 2025, 0.49% in Q3 2025, and 0.46% in Q2 2025.